Medical Extrusion Tubing Market Size, Trends & Growth Opportunity By Product Family, By Material Type, By Medical Application, By Device Component, By Region and Forecast Till 2030

Report ID : AMR1006171 | Industries : Healthcare | Published On :September 2026 | Page Count : 269

Request Sample
Ask for Customization

Medical Extrusion Tubing Market Overview & Definition

The global medical extrusion tubing market covers the polymer tubing components that medical device original equipment manufacturers (OEMs) build into catheters, delivery systems, guide catheters, introducers and other minimally invasive devices, rather than the finished, cleared devices themselves.

This report describes extrusion tubing strictly as a component supply category. It makes no claim about the clinical performance, safety or regulatory approval status of any finished device built from this tubing.

The market spans ten product families, from single-lumen and multi-lumen medical tubing through co-extruded, multi-layer and balloon catheter tubing to micro-extrusion and specialty extrusion profiles.

Ten polymer material types underpin these product families, led by Pebax, nylon, polyurethane, PTFE, FEP and PEEK, alongside polyethylene, polypropylene, silicone-compatible extrusions and bioabsorbable polymers.

Six manufacturing complexity tiers, from standard extrusion through precision, tight-tolerance and thin-wall extrusion to multi-layer extrusion and hybrid component manufacturing, determine which product families and regulatory classes a given supplier can realistically support.

Ten medical application categories and eight device component types connect tubing construction to end use, spanning cardiovascular, electrophysiology, neurovascular, structural heart, endoscopy, urology, gastroenterology, peripheral vascular, drug delivery and diagnostic devices.

Six customer segments, from global medical device OEMs and mid-sized device manufacturers to emerging medical technology companies, contract device manufacturers, catheter specialists and interventional device developers, define who buys this tubing.

Geographically, this report covers North America (the United States, including California, Massachusetts, Minnesota, Indiana, Texas and Pennsylvania, and Canada), Europe (Germany, Ireland, Switzerland, the United Kingdom and the Netherlands) and Asia-Pacific (China, Japan, South Korea, Singapore and India).

Key terms used throughout this report: a lumen is a hollow channel running the length of a tubing extrusion; co-extrusion combines two or more polymer layers in a single extrusion pass; Pebax is a polyether block amide polymer widely used in catheter shafts; a catheter shaft is the elongated tubular body of a catheter; and an OEM is an original equipment manufacturer, the medical device company that specifies and purchases tubing components.

Regulatory classification terms referenced in this report, including Class I, Class II, Class III and Combination Product device programs, are used strictly as named market categories describing which device program a given tubing construction is intended to support, never as a claim about a specific device's actual approval status.

This overview establishes scope only. Detailed segmentation, regional footprint and supplier structure follow in the sections below and across the five detailed pages that accompany this report.

Market Size & Growth Forecast (2026 to 2030)

The global medical extrusion tubing market is estimated at approximately USD 12.5 Billion in 2025 and is projected to reach approximately USD 18.4 Billion by 2030, expanding at a compound annual growth rate of roughly 8.0 percent.

The estimate covers polymer tubing components supplied to medical device OEMs, catheter specialists and contract manufacturers, and excludes the finished, cleared devices built from that tubing.

Single-Lumen and Multi-Lumen Medical Tubing together account for the largest product family category by supply volume, while Micro-Extrusion Tubing and Multi-Layer Tubing form a fast-growing product family category tied to device miniaturization.

Pebax and Nylon together account for the largest material type category by volume, while PEEK and Bioabsorbable Polymers form a fast-growing material type category among advanced structural heart and drug delivery programs.

Cardiovascular Devices and Electrophysiology Devices together account for the largest medical application category, while Neurovascular Devices and Structural Heart Devices form a fast-growing application category tied to rising minimally invasive procedure volumes.

Global Medical Device OEMs account for the largest customer segment category by purchase value, while Contract Device Manufacturers form a fast-growing customer segment category as mid-sized and emerging device companies outsource tubing production.

North America accounts for the largest regional concentration in this report, while Asia-Pacific forms a fast-growing region tied to expanding catheter manufacturing clusters in China, Japan and South Korea.

Standard and Precision Extrusion together account for the largest manufacturing complexity category by volume, while Tight-Tolerance and Thin-Wall Extrusion form a fast-growing complexity category as device miniaturization accelerates.

The forecast assumes device OEM product development cycles and regulatory approval timelines continue broadly on recent patterns, and a sustained shift in either would move the trajectory.

This estimate reflects third-party industry research triangulated for this report. Full methodology appears in the Research Methodology section below.

MetricValue
Market Size (2025)Approximately USD 12.5 Billion
Forecast Size (2030)Approximately USD 18.4 Billion
CAGR (2025-2030)Approximately 8.0%
Base Year2025
Forecast Period2026-2030 (5-year)
Scope NotePolymer tubing components supplied to medical device OEMs, catheter specialists and contract manufacturers; excludes finished, cleared medical devices
Largest Product Family CategorySingle-Lumen and Multi-Lumen Medical Tubing
Fastest-Growing Product Family CategoryMicro-Extrusion Tubing and Multi-Layer Tubing
Largest Medical Application CategoryCardiovascular Devices and Electrophysiology Devices
Fastest-Growing Medical Application CategoryNeurovascular Devices and Structural Heart Devices
Largest Regional ConcentrationNorth America
Fastest-Growing RegionAsia-Pacific

Market Drivers

Rising procedural volumes in minimally invasive cardiovascular, electrophysiology and neurovascular interventions, which directly expand demand for precision catheter shafts and delivery-system tubing.

Continued device miniaturization pushing OEMs toward micro-extrusion and thin-wall, tight-tolerance tubing capabilities that only a subset of specialist extruders can reliably supply.

Growth in structural heart and drug delivery device categories, both of which rely on multi-layer and co-extruded tubing constructions with tighter dimensional and biocompatibility requirements than legacy single-lumen designs.

OEM preference for approved-supplier and long-term supply agreement models over spot sourcing, favoring extruders with established quality systems and regulatory track records.

Expansion of contract device manufacturing as mid-sized and emerging medical technology companies outsource tubing and component production rather than build in-house extrusion capacity.

Growing adoption of hybrid component manufacturing, in which a single supplier combines extrusion with downstream assembly, reducing the number of vendors an OEM must qualify for a single device program.

MARKET SHIFT

Device miniaturization is pushing a growing share of new OEM programs toward micro-extrusion and thin-wall, tight-tolerance capability that only a small group of specialist extruders currently offer, concentrating new program awards among suppliers that invested early in this capability rather than spreading demand broadly across the existing supplier base.

 

Market Restraints

Regulatory delays tied to FDA and EU MDR review cycles that lengthen qualification timelines for new tubing materials and constructions before OEM programs can convert to commercial volume.

Raw material shortages and price volatility in specialty polymers such as Pebax and PEEK, which compress margins for extruders locked into fixed-price OEM contracts.

High capital and validation costs for precision and tight-tolerance extrusion lines, creating a barrier to entry that concentrates advanced capability among a small group of established suppliers.

Supplier consolidation pressure from large OEMs seeking to reduce their approved vendor base, squeezing smaller regional extruders out of long-term programs.

COMPETITIVE WATCH

Large OEMs continuing to narrow their approved supplier lists is concentrating long-term program awards among extruders that already hold multiple qualified device classes, making it progressively harder for a smaller regional extruder to win a first qualification slot without a differentiated capability such as micro-extrusion or hybrid component manufacturing.

 

Market Opportunities

Considerable untapped opportunity in advanced catheter components for structural heart and neurovascular platforms, where few extruders currently offer qualified multi-layer or bioabsorbable-polymer capability.

Regional supply gaps in Asia-Pacific catheter manufacturing clusters as OEMs seek dual-sourcing outside established European and United States manufacturing hubs.

Growing demand for hybrid component manufacturing that combines extrusion with downstream assembly, letting suppliers move up the value chain from raw tubing to finished sub-assemblies.

Development-partnership models that embed extruders early in OEM product design, converting a commodity extrusion relationship into a defensible, design-locked supply position.

Product Families, Manufacturing Complexity and Regulatory Classification

Ten product families, from single-lumen and multi-lumen medical tubing through micro-extrusion and specialty extrusion profiles, span six manufacturing complexity tiers and four regulatory classification categories, with manufacturing complexity generally determining which regulatory class a given construction can realistically support.

Standard and precision extrusion cover the majority of single-lumen and braided tubing volume, while tight-tolerance and thin-wall extrusion are increasingly required for micro-extrusion and multi-layer constructions used in Class II and Class III device programs.

Materials Used in Medical Extrusion Tubing

Ten polymer material types, led by Pebax, nylon, polyurethane, PTFE, FEP and PEEK, define which construction a given device application can realistically specify, well before manufacturing complexity is considered.

Bioabsorbable polymers and silicone-compatible extrusions remain a comparatively small but fast-growing share of total material volume, concentrated in structural heart and drug delivery applications.

Medical Applications and Device Components

Ten medical application categories map onto eight device component types, with catheter shafts and balloon components serving as the highest-volume categories across cardiovascular and electrophysiology applications.

Neurovascular and structural heart applications generally require the most complex device component constructions, including multi-layer delivery systems and reinforced access systems.

Customer Segments and Go-to-Market Structure

Six customer segments, from global medical device OEMs to catheter specialists and interventional device developers, connect to four go-to-market structures, with larger OEMs generally favoring long-term supply agreements over spot-sourced contract manufacturing.

Emerging medical technology companies and contract device manufacturers together represent a growing share of new supplier qualification activity, reflecting continued outsourcing across the industry.

Medical Extrusion Tubing Market, By Region

North America leads the global medical extrusion tubing market, anchored by concentrated device OEM and catheter manufacturing activity across California, Massachusetts, Minnesota, Indiana, Texas and Pennsylvania in the United States, and Ontario and Quebec in Canada.

Europe forms the second-largest regional concentration, with Germany, Ireland, Switzerland, the United Kingdom and the Netherlands together hosting established medical device manufacturing hubs and a deep base of specialist extruders.

Asia-Pacific is the fastest-growing region, with China, Japan, South Korea, Singapore and India together expanding catheter and device component manufacturing capacity as global OEMs pursue dual-sourcing outside North America and Europe.

Ireland in particular has developed a concentrated cluster of medical device and component manufacturing activity that serves OEM customers across both the European and North American markets.

Regional supplier qualification cycles generally track each region's device OEM concentration, with North America and Europe carrying the longest-established approved supplier relationships and Asia-Pacific representing the newest qualification activity.

REGIONAL OPPORTUNITY

Asia-Pacific catheter manufacturing clusters in China, Japan and South Korea are drawing new dual-sourcing interest from global OEMs seeking to diversify beyond established North American and European supplier relationships, creating a genuine opening for regional extruders that can demonstrate the quality systems and regulatory track record OEMs require before a first qualification.

 

Leading Companies

Martech Medical Products, Zeus Industrial Products, Teleflex Medical OEM, Spectrum Plastics Group, Freudenberg Medical, Putnam Plastics, Nordson MEDICAL, Vention Medical, TekniPlex Healthcare, Raumedic, New England Tubing Technologies, MDC Industries, Optinova, Lubrizol Life Science Health, Viant Medical, Creganna Medical, TE Connectivity Medical and MicroLumen are covered in the full report. An introduction to the leading medical extrusion tubing manufacturers by capability group is available on this page.

Beyond This Page

The full report extends well past the segmentation summarised here and into the commercial detail that shapes how extrusion tubing supply is actually won.

Buyer intelligence maps the buyer ecosystem across global OEMs, catheter specialists, contract manufacturers and interventional device developers in full, including a dedicated strategic relevance assessment for Martech Medical.

Decision-maker mapping covers vendor selection criteria, contract value bands and typical sales cycle length across the customer segments this report tracks.

Competitive benchmarking compares suppliers across estimated market position, pricing positioning, production capacity, geographic reach, OEM relationships, quality certifications and innovation capabilities.

The market playbook covers raw material economics, labor and manufacturing cost drivers, FDA and MDR compliance shifts, and material innovation reshaping ongoing production.

Pricing and procurement chapters cover extrusion tubing pricing structure, material-based pricing analysis, buyer and supplier negotiation dynamics and total cost of ownership analysis.

Go-to-market chapters set out strategic OEM targeting, development partnership models, new geography expansion pathways and major medical technology trade fair activity.

Company profiles cover eighteen manufacturers and specialists across geographic footprint, product portfolio, certifications and recent developments.

Frequently Asked Questions

The global medical extrusion tubing market is estimated at approximately USD 12.5 Billion in 2025 and is projected to reach approximately USD 18.4 Billion by 2030, expanding at a compound annual growth rate of roughly 8.0 percent.

Polymer tubing components that medical device OEMs build into catheters, delivery systems, guide catheters, introducers and other minimally invasive devices. This report describes the category strictly as a component supply market.

Single-Lumen and Multi-Lumen Medical Tubing together account for the largest product family category by supply volume, while Micro-Extrusion Tubing and Multi-Layer Tubing form a fast-growing category tied to device miniaturization.

Pebax and Nylon together account for the largest material type category by volume, while PEEK and Bioabsorbable Polymers form a fast-growing category among advanced structural heart and drug delivery programs.

North America leads the global market, anchored by concentrated device OEM and catheter manufacturing activity in the United States and Canada, while Asia-Pacific is the fastest-growing region.

Cardiovascular Devices and Electrophysiology Devices together account for the largest application category, while Neurovascular Devices and Structural Heart Devices form a fast-growing category tied to rising minimally invasive procedure volumes.

Global Medical Device OEMs account for the largest customer segment by purchase value, while Contract Device Manufacturers form a fast-growing segment as mid-sized and emerging device companies outsource tubing production.

This report tracks Class I, Class II, Class III and Combination Product device programs strictly as named market categories describing which device program a tubing construction is intended to support, not as a claim about any specific device's approval status.

Inquire Before Buying Request Free Sample Ask For Discount

1. Introduction

1.1. Objective of the Study

1.2. Market Definition

1.3. Market Scope

2. Executive Summary

3. Extrusion Tubing Market Analysis and Forecast (2026–2030)

3.1. Overview

3.2. Market Dynamics

3.3. Drivers

3.3.1. Rising Procedural Volumes in Minimally Invasive Cardiovascular, Electrophysiology and Neurovascular Interventions, Which Directly Expand Demand for Precision Catheter Shafts and Delivery-System Tubing.

3.3.2. Continued Device Miniaturization Pushing OEMs Toward Micro-Extrusion and Thin-Wall, Tight-Tolerance Tubing Capabilities That Only a Subset of Specialist Extruders Can Reliably Supply.

3.3.3. Growth in Structural Heart and Drug Delivery Device Categories, Both of Which Rely on Multi-Layer and Co-Extruded Tubing Constructions with Tighter Dimensional and Biocompatibility Requirements Than Legacy Single-Lumen Designs.

3.3.4. OEM Preference for Approved-Supplier and Long-Term Supply Agreement Models Over Spot Sourcing, Favoring Extruders with Established Quality Systems and Regulatory Track Records.

3.3.5. Expansion of Contract Device Manufacturing as Mid-Sized and Emerging MedTech Companies Outsource Tubing and Component Production Rather Than Build In-House Extrusion Capacity.

3.4. Restraints

3.4.1. Regulatory Delays Tied to FDA and EU MDR Review Cycles That Lengthen Qualification Timelines for New Tubing Materials and Constructions Before OEM Programs Can Convert to Commercial Volume.

3.4.2. Raw Material Shortages and Price Volatility in Specialty Polymers Such as Pebax and PEEK, Which Compress Margins for Extruders Locked into Fixed-Price OEM Contracts.

3.4.3. High Capital and Validation Costs for Precision and Tight-Tolerance Extrusion Lines, Creating a Barrier to Entry That Concentrates Advanced Capability Among a Small Group of Established Suppliers.

3.4.4. Supplier Consolidation Pressure from Large OEMs Seeking to Reduce Their Approved Vendor Base, Squeezing Smaller Regional Extruders Out of Long-Term Programs.

3.5. Opportunities

3.5.1. White Space in Advanced Catheter Components for Structural Heart and Neurovascular Platforms, Where Few Extruders Currently Offer Qualified Multi-Layer or Bioabsorbable-Polymer Capability.

3.5.2. Regional Supply Gaps in Asia-Pacific Catheter Manufacturing Clusters as OEMs Seek Dual-Sourcing Outside Established European and U.S. Manufacturing Hubs.

3.5.3. Growing Demand for Hybrid Component Manufacturing That Combines Extrusion with Downstream Assembly, Letting Suppliers Move Up the Value Chain from Raw Tubing to Finished Sub-Assemblies.

3.5.4. Development-Partnership Models That Embed Extruders Early in OEM Product Design, Converting a Commodity Extrusion Relationship into a Defensible, Design-Locked Supply Position.

3.6. Porter's Five Forces Model

3.7. Value Chain Analysis

4. Product Family

4.1. Single-Lumen Medical Tubing

4.2. Multi-Lumen Medical Tubing

4.3. Braided Tubing

4.4. Co-Extruded Tubing

4.5. Multi-Layer Tubing

4.6. Balloon Catheter Tubing

4.7. Heat-Shrink Tubing

4.8. Micro-Extrusion Tubing

4.9. Reinforced Tubing

4.10. Specialty Extrusion Profiles

5. Material Type

5.1. Pebax

5.2. Nylon

5.3. Polyurethane

5.4. PTFE

5.5. FEP

5.6. PEEK

5.7. Polyethylene

5.8. Polypropylene

5.9. Silicone-Compatible Extrusions

5.10. Bioabsorbable Polymers

6. Manufacturing Complexity

6.1. Standard Extrusion

6.2. Precision Extrusion

6.3. Tight-Tolerance Extrusion

6.4. Thin-Wall Extrusion

6.5. Multi-Layer Extrusion

6.6. Hybrid Component Manufacturing

7. Medical Application

7.1. Cardiovascular Devices

7.2. Electrophysiology Devices

7.3. Neurovascular Devices

7.4. Endoscopy Devices

7.5. Structural Heart Devices

7.6. Urology Devices

7.7. Gastroenterology Devices

7.8. Peripheral Vascular Devices

7.9. Drug Delivery Systems

7.10. Diagnostic Devices

8. Device Component Type

8.1. Catheter Shafts

8.2. Guide Catheter Components

8.3. Balloon Catheter Components

8.4. Delivery Systems

8.5. Access Systems

8.6. Introducer Systems

8.7. Medical Fluid Management Systems

8.8. Surgical Instrument Components

9. Customer Segment

9.1. Global Medical Device OEMs

9.2. Mid-Sized Device Manufacturers

9.3. Emerging Medical Technology Companies

9.4. Contract Device Manufacturers

9.5. Catheter Specialists

9.6. Interventional Device Developers

10. Regulatory Classification Support

10.1. Class I Device Programs

10.2. Class II Device Programs

10.3. Class III Device Programs

10.4. Combination Product Programs

11. Go-to-Market Structure

11.1. Direct OEM Supply

11.2. Strategic Development Partnerships

11.3. Contract Manufacturing Programs

11.4. Long-Term Supply Agreements

12. Buyer Intelligence and Demand Landscape

12.1. Buyer Segmentation

12.1.1. Tier-1 Global Medical Device OEMs

12.1.2. Interventional Device Manufacturers

12.1.3. Catheter Specialists

12.1.4. Structural Heart Device Companies

12.1.5. Neurovascular Device Manufacturers

12.1.6. Contract Medical Device Manufacturers

12.2. Buyer Industries

12.2.1. Cardiovascular Devices

12.2.2. Electrophysiology

12.2.3. Neurovascular

12.2.4. Endoscopy

12.2.5. Surgical Devices

12.2.6. Drug Delivery Systems

12.3. Buyer Company Types

12.3.1. Public Medical Technology Companies

12.3.2. Venture-Backed MedTech Firms

12.3.3. Private Device Manufacturers

12.3.4. Contract Manufacturing Organizations

12.4. Country-Wise Buyer Mapping

12.4.1. United States

12.4.2. Germany

12.4.3. Ireland

12.4.4. Switzerland

12.4.5. China

12.4.6. Japan

12.5. Regional Demand Clusters

12.5.1. U.S. Medical Device Corridors

12.5.2. European MedTech Manufacturing Hubs

12.5.3. Asian Catheter Manufacturing Clusters

12.6. Buyer Scale Classification

12.6.1. Global OEMs

12.6.2. Regional OEMs

12.6.3. Emerging Innovators

12.6.4. Start-Up Device Developers

12.7. Procurement Models

12.7.1. Approved Supplier Programs

12.7.2. Development Partnerships

12.7.3. Multi-Year Supply Contracts

12.7.4. Dual-Sourcing Strategies

12.8. Buying Triggers

12.8.1. New Product Launches

12.8.2. Regulatory Approvals

12.8.3. Capacity Expansion

12.8.4. Material Innovation Requirements

12.8.5. Supplier Consolidation

12.9. Decision-Maker Roles

12.9.1. VP Operations

12.9.2. Strategic Sourcing Director

12.9.3. Engineering Director

12.9.4. R&D Director

12.9.5. Supply Chain Director

12.9.6. Quality Director

12.10. Budget Ownership

12.10.1. Procurement

12.10.2. Engineering

12.10.3. Product Development

12.10.4. Operations

12.11. Vendor Selection Criteria

12.11.1. Quality Systems

12.11.2. Process Capability

12.11.3. Regulatory Compliance

12.11.4. Engineering Support

12.11.5. Cost Competitiveness

12.11.6. Delivery Reliability

12.12. Contract Value Bands

12.12.1. Prototype Programs

12.12.2. Low-Volume Commercial Programs

12.12.3. Mid-Scale Production Contracts

12.12.4. Enterprise Supply Agreements

12.13. Sales Cycle Length

12.13.1. Qualification Phase

12.13.2. Validation Phase

12.13.3. Regulatory Approval Phase

12.13.4. Commercial Ramp-Up

12.14. Strategic Relevance for Martech Medical

12.14.1. Strategic Relevance for Martech Medical

13. North America Medical Extrusion Tubing Market - Global View with Spotlight on Product Families, Materials, Manufacturing Complexity, Medical Applications, Device Components, Customer Segments, Regulatory Classification, Buyer Intelligence, Competitive Benchmarking and Growth Opportunity Analysis Market Analysis and Forecast (2026–2030)

13.1. Introduction

13.2. Market Share Analysis

13.3. Market Size and Forecast

13.4. Market Size and Forecast, By Geography

13.4.1. United States

13.4.1.1. Market Share Analysis

13.4.1.2. Market Size and Forecast

13.4.1.3. By Product

13.4.1.4. By Technology

13.4.1.5. By Application

13.4.1.6. By Customer

13.4.1.7. California

13.4.1.7.1. Market Share Analysis

13.4.1.7.2. Market Size and Forecast

13.4.1.7.3. By Product

13.4.1.7.4. By Technology

13.4.1.7.5. By Application

13.4.1.7.6. By Customer

13.4.1.8. Massachusetts

13.4.1.8.1. Market Share Analysis

13.4.1.8.2. Market Size and Forecast

13.4.1.8.3. By Product

13.4.1.8.4. By Technology

13.4.1.8.5. By Application

13.4.1.8.6. By Customer

13.4.1.9. Minnesota

13.4.1.9.1. Market Share Analysis

13.4.1.9.2. Market Size and Forecast

13.4.1.9.3. By Product

13.4.1.9.4. By Technology

13.4.1.9.5. By Application

13.4.1.9.6. By Customer

13.4.1.10. Indiana

13.4.1.10.1. Market Share Analysis

13.4.1.10.2. Market Size and Forecast

13.4.1.10.3. By Product

13.4.1.10.4. By Technology

13.4.1.10.5. By Application

13.4.1.10.6. By Customer

13.4.1.11. Texas

13.4.1.11.1. Market Share Analysis

13.4.1.11.2. Market Size and Forecast

13.4.1.11.3. By Product

13.4.1.11.4. By Technology

13.4.1.11.5. By Application

13.4.1.11.6. By Customer

13.4.1.12. Pennsylvania

13.4.1.12.1. Market Share Analysis

13.4.1.12.2. Market Size and Forecast

13.4.1.12.3. By Product

13.4.1.12.4. By Technology

13.4.1.12.5. By Application

13.4.1.12.6. By Customer

13.4.2. Canada

13.4.2.1. Market Share Analysis

13.4.2.2. Market Size and Forecast

13.4.2.3. By Product

13.4.2.4. By Technology

13.4.2.5. By Application

13.4.2.6. By Customer

13.4.2.7. Ontario

13.4.2.7.1. Market Share Analysis

13.4.2.7.2. Market Size and Forecast

13.4.2.7.3. By Product

13.4.2.7.4. By Technology

13.4.2.7.5. By Application

13.4.2.7.6. By Customer

13.4.2.8. Quebec

13.4.2.8.1. Market Share Analysis

13.4.2.8.2. Market Size and Forecast

13.4.2.8.3. By Product

13.4.2.8.4. By Technology

13.4.2.8.5. By Application

13.4.2.8.6. By Customer

14. Competition Analysis

14.1. Market Positioning Overview

14.1.1. Global vs Regional Competitor Assessment

14.1.2. Product Breadth Comparison

14.1.3. Engineering Support Capabilities

14.1.4. Material Expertise Comparison

14.1.5. Value Proposition Benchmarking

14.2. Competitive Benchmarking Metrics

14.2.1. Market Share

14.2.2. Pricing Positioning

14.2.3. Production Capacity

14.2.4. Geographic Reach

14.2.5. OEM Relationships

14.2.6. Quality Certifications

14.2.7. Innovation Capabilities

14.3. Strategic Moves

14.3.1. Capacity Expansions

14.3.2. New Manufacturing Facilities

14.3.3. Material Technology Partnerships

14.3.4. Product Launches

14.3.5. Strategic Acquisitions

14.3.6. Regional Expansion Initiatives

14.4. Competitive Mapping & Gaps

14.4.1. Micro-Extrusion Opportunities

14.4.2. Advanced Catheter Components White Space

14.4.3. Regional Supply Gaps

14.4.4. Emerging Device Segment Opportunities

14.4.5. High-Growth Customer Niches

15. Company Profiles

15.1. Martech Medical Products

15.1.1. Overview

15.1.2. Headquarters

15.1.3. Ownership Structure

15.1.4. Founding Year

15.1.5. Workforce Estimate

15.1.6. Geographic Footprint

15.1.7. Product Portfolio

15.1.8. Customer Segments

15.1.9. Distribution and GTM Strategy

15.1.10. Financial Highlights

15.1.11. Certifications

15.1.12. Partnerships and Alliances

15.1.13. R&D Capabilities

15.1.14. Recent Developments

15.1.15. SWOT Snapshot

15.2. Zeus Industrial Products

15.2.1. Overview

15.2.2. Headquarters

15.2.3. Ownership Structure

15.2.4. Founding Year

15.2.5. Workforce Estimate

15.2.6. Geographic Footprint

15.2.7. Product Portfolio

15.2.8. Customer Segments

15.2.9. Distribution and GTM Strategy

15.2.10. Financial Highlights

15.2.11. Certifications

15.2.12. Partnerships and Alliances

15.2.13. R&D Capabilities

15.2.14. Recent Developments

15.2.15. SWOT Snapshot

15.3. Teleflex Medical OEM

15.3.1. Overview

15.3.2. Headquarters

15.3.3. Ownership Structure

15.3.4. Founding Year

15.3.5. Workforce Estimate

15.3.6. Geographic Footprint

15.3.7. Product Portfolio

15.3.8. Customer Segments

15.3.9. Distribution and GTM Strategy

15.3.10. Financial Highlights

15.3.11. Certifications

15.3.12. Partnerships and Alliances

15.3.13. R&D Capabilities

15.3.14. Recent Developments

15.3.15. SWOT Snapshot

15.4. Spectrum Plastics Group

15.4.1. Overview

15.4.2. Headquarters

15.4.3. Ownership Structure

15.4.4. Founding Year

15.4.5. Workforce Estimate

15.4.6. Geographic Footprint

15.4.7. Product Portfolio

15.4.8. Customer Segments

15.4.9. Distribution and GTM Strategy

15.4.10. Financial Highlights

15.4.11. Certifications

15.4.12. Partnerships and Alliances

15.4.13. R&D Capabilities

15.4.14. Recent Developments

15.4.15. SWOT Snapshot

15.5. Freudenberg Medical

15.5.1. Overview

15.5.2. Headquarters

15.5.3. Ownership Structure

15.5.4. Founding Year

15.5.5. Workforce Estimate

15.5.6. Geographic Footprint

15.5.7. Product Portfolio

15.5.8. Customer Segments

15.5.9. Distribution and GTM Strategy

15.5.10. Financial Highlights

15.5.11. Certifications

15.5.12. Partnerships and Alliances

15.5.13. R&D Capabilities

15.5.14. Recent Developments

15.5.15. SWOT Snapshot

15.6. Putnam Plastics

15.6.1. Overview

15.6.2. Headquarters

15.6.3. Ownership Structure

15.6.4. Founding Year

15.6.5. Workforce Estimate

15.6.6. Geographic Footprint

15.6.7. Product Portfolio

15.6.8. Customer Segments

15.6.9. Distribution and GTM Strategy

15.6.10. Financial Highlights

15.6.11. Certifications

15.6.12. Partnerships and Alliances

15.6.13. R&D Capabilities

15.6.14. Recent Developments

15.6.15. SWOT Snapshot

15.7. Nordson MEDICAL

15.7.1. Overview

15.7.2. Headquarters

15.7.3. Ownership Structure

15.7.4. Founding Year

15.7.5. Workforce Estimate

15.7.6. Geographic Footprint

15.7.7. Product Portfolio

15.7.8. Customer Segments

15.7.9. Distribution and GTM Strategy

15.7.10. Financial Highlights

15.7.11. Certifications

15.7.12. Partnerships and Alliances

15.7.13. R&D Capabilities

15.7.14. Recent Developments

15.7.15. SWOT Snapshot

15.8. Vention Medical

15.8.1. Overview

15.8.2. Headquarters

15.8.3. Ownership Structure

15.8.4. Founding Year

15.8.5. Workforce Estimate

15.8.6. Geographic Footprint

15.8.7. Product Portfolio

15.8.8. Customer Segments

15.8.9. Distribution and GTM Strategy

15.8.10. Financial Highlights

15.8.11. Certifications

15.8.12. Partnerships and Alliances

15.8.13. R&D Capabilities

15.8.14. Recent Developments

15.8.15. SWOT Snapshot

15.9. TekniPlex Healthcare

15.9.1. Overview

15.9.2. Headquarters

15.9.3. Ownership Structure

15.9.4. Founding Year

15.9.5. Workforce Estimate

15.9.6. Geographic Footprint

15.9.7. Product Portfolio

15.9.8. Customer Segments

15.9.9. Distribution and GTM Strategy

15.9.10. Financial Highlights

15.9.11. Certifications

15.9.12. Partnerships and Alliances

15.9.13. R&D Capabilities

15.9.14. Recent Developments

15.9.15. SWOT Snapshot

15.10. Raumedic

15.10.1. Overview

15.10.2. Headquarters

15.10.3. Ownership Structure

15.10.4. Founding Year

15.10.5. Workforce Estimate

15.10.6. Geographic Footprint

15.10.7. Product Portfolio

15.10.8. Customer Segments

15.10.9. Distribution and GTM Strategy

15.10.10. Financial Highlights

15.10.11. Certifications

15.10.12. Partnerships and Alliances

15.10.13. R&D Capabilities

15.10.14. Recent Developments

15.10.15. SWOT Snapshot

15.11. New England Tubing Technologies

15.11.1. Overview

15.11.2. Headquarters

15.11.3. Ownership Structure

15.11.4. Founding Year

15.11.5. Workforce Estimate

15.11.6. Geographic Footprint

15.11.7. Product Portfolio

15.11.8. Customer Segments

15.11.9. Distribution and GTM Strategy

15.11.10. Financial Highlights

15.11.11. Certifications

15.11.12. Partnerships and Alliances

15.11.13. R&D Capabilities

15.11.14. Recent Developments

15.11.15. SWOT Snapshot

15.12. MDC Industries

15.12.1. Overview

15.12.2. Headquarters

15.12.3. Ownership Structure

15.12.4. Founding Year

15.12.5. Workforce Estimate

15.12.6. Geographic Footprint

15.12.7. Product Portfolio

15.12.8. Customer Segments

15.12.9. Distribution and GTM Strategy

15.12.10. Financial Highlights

15.12.11. Certifications

15.12.12. Partnerships and Alliances

15.12.13. R&D Capabilities

15.12.14. Recent Developments

15.12.15. SWOT Snapshot

15.13. Optinova

15.13.1. Overview

15.13.2. Headquarters

15.13.3. Ownership Structure

15.13.4. Founding Year

15.13.5. Workforce Estimate

15.13.6. Geographic Footprint

15.13.7. Product Portfolio

15.13.8. Customer Segments

15.13.9. Distribution and GTM Strategy

15.13.10. Financial Highlights

15.13.11. Certifications

15.13.12. Partnerships and Alliances

15.13.13. R&D Capabilities

15.13.14. Recent Developments

15.13.15. SWOT Snapshot

15.14. Lubrizol Life Science Health

15.14.1. Overview

15.14.2. Headquarters

15.14.3. Ownership Structure

15.14.4. Founding Year

15.14.5. Workforce Estimate

15.14.6. Geographic Footprint

15.14.7. Product Portfolio

15.14.8. Customer Segments

15.14.9. Distribution and GTM Strategy

15.14.10. Financial Highlights

15.14.11. Certifications

15.14.12. Partnerships and Alliances

15.14.13. R&D Capabilities

15.14.14. Recent Developments

15.14.15. SWOT Snapshot

15.15. Viant Medical

15.15.1. Overview

15.15.2. Headquarters

15.15.3. Ownership Structure

15.15.4. Founding Year

15.15.5. Workforce Estimate

15.15.6. Geographic Footprint

15.15.7. Product Portfolio

15.15.8. Customer Segments

15.15.9. Distribution and GTM Strategy

15.15.10. Financial Highlights

15.15.11. Certifications

15.15.12. Partnerships and Alliances

15.15.13. R&D Capabilities

15.15.14. Recent Developments

15.15.15. SWOT Snapshot

15.16. Creganna Medical

15.16.1. Overview

15.16.2. Headquarters

15.16.3. Ownership Structure

15.16.4. Founding Year

15.16.5. Workforce Estimate

15.16.6. Geographic Footprint

15.16.7. Product Portfolio

15.16.8. Customer Segments

15.16.9. Distribution and GTM Strategy

15.16.10. Financial Highlights

15.16.11. Certifications

15.16.12. Partnerships and Alliances

15.16.13. R&D Capabilities

15.16.14. Recent Developments

15.16.15. SWOT Snapshot

15.17. TE Connectivity Medical

15.17.1. Overview

15.17.2. Headquarters

15.17.3. Ownership Structure

15.17.4. Founding Year

15.17.5. Workforce Estimate

15.17.6. Geographic Footprint

15.17.7. Product Portfolio

15.17.8. Customer Segments

15.17.9. Distribution and GTM Strategy

15.17.10. Financial Highlights

15.17.11. Certifications

15.17.12. Partnerships and Alliances

15.17.13. R&D Capabilities

15.17.14. Recent Developments

15.17.15. SWOT Snapshot

15.18. MicroLumen

15.18.1. Overview

15.18.2. Headquarters

15.18.3. Ownership Structure

15.18.4. Founding Year

15.18.5. Workforce Estimate

15.18.6. Geographic Footprint

15.18.7. Product Portfolio

15.18.8. Customer Segments

15.18.9. Distribution and GTM Strategy

15.18.10. Financial Highlights

15.18.11. Certifications

15.18.12. Partnerships and Alliances

15.18.13. R&D Capabilities

15.18.14. Recent Developments

15.18.15. SWOT Snapshot

Frequently Asked Questions

The global medical extrusion tubing market is estimated at approximately USD 12.5 Billion in 2025 and is projected to reach approximately USD 18.4 Billion by 2030, expanding at a compound annual growth rate of roughly 8.0 percent.

Polymer tubing components that medical device OEMs build into catheters, delivery systems, guide catheters, introducers and other minimally invasive devices. This report describes the category strictly as a component supply market.

Single-Lumen and Multi-Lumen Medical Tubing together account for the largest product family category by supply volume, while Micro-Extrusion Tubing and Multi-Layer Tubing form a fast-growing category tied to device miniaturization.

Pebax and Nylon together account for the largest material type category by volume, while PEEK and Bioabsorbable Polymers form a fast-growing category among advanced structural heart and drug delivery programs.

North America leads the global market, anchored by concentrated device OEM and catheter manufacturing activity in the United States and Canada, while Asia-Pacific is the fastest-growing region.

Cardiovascular Devices and Electrophysiology Devices together account for the largest application category, while Neurovascular Devices and Structural Heart Devices form a fast-growing category tied to rising minimally invasive procedure volumes.

Global Medical Device OEMs account for the largest customer segment by purchase value, while Contract Device Manufacturers form a fast-growing segment as mid-sized and emerging device companies outsource tubing production.

This report tracks Class I, Class II, Class III and Combination Product device programs strictly as named market categories describing which device program a tubing construction is intended to support, not as a claim about any specific device's approval status.

Inquire Before Buying Request Free Sample Ask For Discount

Medical Extrusion Tubing Market Overview & Definition

The global medical extrusion tubing market covers the polymer tubing components that medical device original equipment manufacturers (OEMs) build into catheters, delivery systems, guide catheters, introducers and other minimally invasive devices, rather than the finished, cleared devices themselves.

This report describes extrusion tubing strictly as a component supply category. It makes no claim about the clinical performance, safety or regulatory approval status of any finished device built from this tubing.

The market spans ten product families, from single-lumen and multi-lumen medical tubing through co-extruded, multi-layer and balloon catheter tubing to micro-extrusion and specialty extrusion profiles.

Ten polymer material types underpin these product families, led by Pebax, nylon, polyurethane, PTFE, FEP and PEEK, alongside polyethylene, polypropylene, silicone-compatible extrusions and bioabsorbable polymers.

Six manufacturing complexity tiers, from standard extrusion through precision, tight-tolerance and thin-wall extrusion to multi-layer extrusion and hybrid component manufacturing, determine which product families and regulatory classes a given supplier can realistically support.

Ten medical application categories and eight device component types connect tubing construction to end use, spanning cardiovascular, electrophysiology, neurovascular, structural heart, endoscopy, urology, gastroenterology, peripheral vascular, drug delivery and diagnostic devices.

Six customer segments, from global medical device OEMs and mid-sized device manufacturers to emerging medical technology companies, contract device manufacturers, catheter specialists and interventional device developers, define who buys this tubing.

Geographically, this report covers North America (the United States, including California, Massachusetts, Minnesota, Indiana, Texas and Pennsylvania, and Canada), Europe (Germany, Ireland, Switzerland, the United Kingdom and the Netherlands) and Asia-Pacific (China, Japan, South Korea, Singapore and India).

Key terms used throughout this report: a lumen is a hollow channel running the length of a tubing extrusion; co-extrusion combines two or more polymer layers in a single extrusion pass; Pebax is a polyether block amide polymer widely used in catheter shafts; a catheter shaft is the elongated tubular body of a catheter; and an OEM is an original equipment manufacturer, the medical device company that specifies and purchases tubing components.

Regulatory classification terms referenced in this report, including Class I, Class II, Class III and Combination Product device programs, are used strictly as named market categories describing which device program a given tubing construction is intended to support, never as a claim about a specific device's actual approval status.

This overview establishes scope only. Detailed segmentation, regional footprint and supplier structure follow in the sections below and across the five detailed pages that accompany this report.

Market Size & Growth Forecast (2026 to 2030)

The global medical extrusion tubing market is estimated at approximately USD 12.5 Billion in 2025 and is projected to reach approximately USD 18.4 Billion by 2030, expanding at a compound annual growth rate of roughly 8.0 percent.

The estimate covers polymer tubing components supplied to medical device OEMs, catheter specialists and contract manufacturers, and excludes the finished, cleared devices built from that tubing.

Single-Lumen and Multi-Lumen Medical Tubing together account for the largest product family category by supply volume, while Micro-Extrusion Tubing and Multi-Layer Tubing form a fast-growing product family category tied to device miniaturization.

Pebax and Nylon together account for the largest material type category by volume, while PEEK and Bioabsorbable Polymers form a fast-growing material type category among advanced structural heart and drug delivery programs.

Cardiovascular Devices and Electrophysiology Devices together account for the largest medical application category, while Neurovascular Devices and Structural Heart Devices form a fast-growing application category tied to rising minimally invasive procedure volumes.

Global Medical Device OEMs account for the largest customer segment category by purchase value, while Contract Device Manufacturers form a fast-growing customer segment category as mid-sized and emerging device companies outsource tubing production.

North America accounts for the largest regional concentration in this report, while Asia-Pacific forms a fast-growing region tied to expanding catheter manufacturing clusters in China, Japan and South Korea.

Standard and Precision Extrusion together account for the largest manufacturing complexity category by volume, while Tight-Tolerance and Thin-Wall Extrusion form a fast-growing complexity category as device miniaturization accelerates.

The forecast assumes device OEM product development cycles and regulatory approval timelines continue broadly on recent patterns, and a sustained shift in either would move the trajectory.

This estimate reflects third-party industry research triangulated for this report. Full methodology appears in the Research Methodology section below.

MetricValue
Market Size (2025)Approximately USD 12.5 Billion
Forecast Size (2030)Approximately USD 18.4 Billion
CAGR (2025-2030)Approximately 8.0%
Base Year2025
Forecast Period2026-2030 (5-year)
Scope NotePolymer tubing components supplied to medical device OEMs, catheter specialists and contract manufacturers; excludes finished, cleared medical devices
Largest Product Family CategorySingle-Lumen and Multi-Lumen Medical Tubing
Fastest-Growing Product Family CategoryMicro-Extrusion Tubing and Multi-Layer Tubing
Largest Medical Application CategoryCardiovascular Devices and Electrophysiology Devices
Fastest-Growing Medical Application CategoryNeurovascular Devices and Structural Heart Devices
Largest Regional ConcentrationNorth America
Fastest-Growing RegionAsia-Pacific

Market Drivers

Rising procedural volumes in minimally invasive cardiovascular, electrophysiology and neurovascular interventions, which directly expand demand for precision catheter shafts and delivery-system tubing.

Continued device miniaturization pushing OEMs toward micro-extrusion and thin-wall, tight-tolerance tubing capabilities that only a subset of specialist extruders can reliably supply.

Growth in structural heart and drug delivery device categories, both of which rely on multi-layer and co-extruded tubing constructions with tighter dimensional and biocompatibility requirements than legacy single-lumen designs.

OEM preference for approved-supplier and long-term supply agreement models over spot sourcing, favoring extruders with established quality systems and regulatory track records.

Expansion of contract device manufacturing as mid-sized and emerging medical technology companies outsource tubing and component production rather than build in-house extrusion capacity.

Growing adoption of hybrid component manufacturing, in which a single supplier combines extrusion with downstream assembly, reducing the number of vendors an OEM must qualify for a single device program.

MARKET SHIFT

Device miniaturization is pushing a growing share of new OEM programs toward micro-extrusion and thin-wall, tight-tolerance capability that only a small group of specialist extruders currently offer, concentrating new program awards among suppliers that invested early in this capability rather than spreading demand broadly across the existing supplier base.

 

Market Restraints

Regulatory delays tied to FDA and EU MDR review cycles that lengthen qualification timelines for new tubing materials and constructions before OEM programs can convert to commercial volume.

Raw material shortages and price volatility in specialty polymers such as Pebax and PEEK, which compress margins for extruders locked into fixed-price OEM contracts.

High capital and validation costs for precision and tight-tolerance extrusion lines, creating a barrier to entry that concentrates advanced capability among a small group of established suppliers.

Supplier consolidation pressure from large OEMs seeking to reduce their approved vendor base, squeezing smaller regional extruders out of long-term programs.

COMPETITIVE WATCH

Large OEMs continuing to narrow their approved supplier lists is concentrating long-term program awards among extruders that already hold multiple qualified device classes, making it progressively harder for a smaller regional extruder to win a first qualification slot without a differentiated capability such as micro-extrusion or hybrid component manufacturing.

 

Market Opportunities

Considerable untapped opportunity in advanced catheter components for structural heart and neurovascular platforms, where few extruders currently offer qualified multi-layer or bioabsorbable-polymer capability.

Regional supply gaps in Asia-Pacific catheter manufacturing clusters as OEMs seek dual-sourcing outside established European and United States manufacturing hubs.

Growing demand for hybrid component manufacturing that combines extrusion with downstream assembly, letting suppliers move up the value chain from raw tubing to finished sub-assemblies.

Development-partnership models that embed extruders early in OEM product design, converting a commodity extrusion relationship into a defensible, design-locked supply position.

Product Families, Manufacturing Complexity and Regulatory Classification

Ten product families, from single-lumen and multi-lumen medical tubing through micro-extrusion and specialty extrusion profiles, span six manufacturing complexity tiers and four regulatory classification categories, with manufacturing complexity generally determining which regulatory class a given construction can realistically support.

Standard and precision extrusion cover the majority of single-lumen and braided tubing volume, while tight-tolerance and thin-wall extrusion are increasingly required for micro-extrusion and multi-layer constructions used in Class II and Class III device programs.

Materials Used in Medical Extrusion Tubing

Ten polymer material types, led by Pebax, nylon, polyurethane, PTFE, FEP and PEEK, define which construction a given device application can realistically specify, well before manufacturing complexity is considered.

Bioabsorbable polymers and silicone-compatible extrusions remain a comparatively small but fast-growing share of total material volume, concentrated in structural heart and drug delivery applications.

Medical Applications and Device Components

Ten medical application categories map onto eight device component types, with catheter shafts and balloon components serving as the highest-volume categories across cardiovascular and electrophysiology applications.

Neurovascular and structural heart applications generally require the most complex device component constructions, including multi-layer delivery systems and reinforced access systems.

Customer Segments and Go-to-Market Structure

Six customer segments, from global medical device OEMs to catheter specialists and interventional device developers, connect to four go-to-market structures, with larger OEMs generally favoring long-term supply agreements over spot-sourced contract manufacturing.

Emerging medical technology companies and contract device manufacturers together represent a growing share of new supplier qualification activity, reflecting continued outsourcing across the industry.

Medical Extrusion Tubing Market, By Region

North America leads the global medical extrusion tubing market, anchored by concentrated device OEM and catheter manufacturing activity across California, Massachusetts, Minnesota, Indiana, Texas and Pennsylvania in the United States, and Ontario and Quebec in Canada.

Europe forms the second-largest regional concentration, with Germany, Ireland, Switzerland, the United Kingdom and the Netherlands together hosting established medical device manufacturing hubs and a deep base of specialist extruders.

Asia-Pacific is the fastest-growing region, with China, Japan, South Korea, Singapore and India together expanding catheter and device component manufacturing capacity as global OEMs pursue dual-sourcing outside North America and Europe.

Ireland in particular has developed a concentrated cluster of medical device and component manufacturing activity that serves OEM customers across both the European and North American markets.

Regional supplier qualification cycles generally track each region's device OEM concentration, with North America and Europe carrying the longest-established approved supplier relationships and Asia-Pacific representing the newest qualification activity.

REGIONAL OPPORTUNITY

Asia-Pacific catheter manufacturing clusters in China, Japan and South Korea are drawing new dual-sourcing interest from global OEMs seeking to diversify beyond established North American and European supplier relationships, creating a genuine opening for regional extruders that can demonstrate the quality systems and regulatory track record OEMs require before a first qualification.

 

Leading Companies

Martech Medical Products, Zeus Industrial Products, Teleflex Medical OEM, Spectrum Plastics Group, Freudenberg Medical, Putnam Plastics, Nordson MEDICAL, Vention Medical, TekniPlex Healthcare, Raumedic, New England Tubing Technologies, MDC Industries, Optinova, Lubrizol Life Science Health, Viant Medical, Creganna Medical, TE Connectivity Medical and MicroLumen are covered in the full report. An introduction to the leading medical extrusion tubing manufacturers by capability group is available on this page.

Beyond This Page

The full report extends well past the segmentation summarised here and into the commercial detail that shapes how extrusion tubing supply is actually won.

Buyer intelligence maps the buyer ecosystem across global OEMs, catheter specialists, contract manufacturers and interventional device developers in full, including a dedicated strategic relevance assessment for Martech Medical.

Decision-maker mapping covers vendor selection criteria, contract value bands and typical sales cycle length across the customer segments this report tracks.

Competitive benchmarking compares suppliers across estimated market position, pricing positioning, production capacity, geographic reach, OEM relationships, quality certifications and innovation capabilities.

The market playbook covers raw material economics, labor and manufacturing cost drivers, FDA and MDR compliance shifts, and material innovation reshaping ongoing production.

Pricing and procurement chapters cover extrusion tubing pricing structure, material-based pricing analysis, buyer and supplier negotiation dynamics and total cost of ownership analysis.

Go-to-market chapters set out strategic OEM targeting, development partnership models, new geography expansion pathways and major medical technology trade fair activity.

Company profiles cover eighteen manufacturers and specialists across geographic footprint, product portfolio, certifications and recent developments.

Frequently Asked Questions

The global medical extrusion tubing market is estimated at approximately USD 12.5 Billion in 2025 and is projected to reach approximately USD 18.4 Billion by 2030, expanding at a compound annual growth rate of roughly 8.0 percent.

Polymer tubing components that medical device OEMs build into catheters, delivery systems, guide catheters, introducers and other minimally invasive devices. This report describes the category strictly as a component supply market.

Single-Lumen and Multi-Lumen Medical Tubing together account for the largest product family category by supply volume, while Micro-Extrusion Tubing and Multi-Layer Tubing form a fast-growing category tied to device miniaturization.

Pebax and Nylon together account for the largest material type category by volume, while PEEK and Bioabsorbable Polymers form a fast-growing category among advanced structural heart and drug delivery programs.

North America leads the global market, anchored by concentrated device OEM and catheter manufacturing activity in the United States and Canada, while Asia-Pacific is the fastest-growing region.

Cardiovascular Devices and Electrophysiology Devices together account for the largest application category, while Neurovascular Devices and Structural Heart Devices form a fast-growing category tied to rising minimally invasive procedure volumes.

Global Medical Device OEMs account for the largest customer segment by purchase value, while Contract Device Manufacturers form a fast-growing segment as mid-sized and emerging device companies outsource tubing production.

This report tracks Class I, Class II, Class III and Combination Product device programs strictly as named market categories describing which device program a tubing construction is intended to support, not as a claim about any specific device's approval status.

Inquire Before Buying Request Free Sample Ask For Discount